Advanced search
Publication Cover
OncoImmunology Volume 1, 2012 - Issue 7
Submit an article Journal homepage
1,056
Views
13
CrossRef citations to date
0
Altmetric
Author's View

Combinatorial Immunotherapy

PD-1 may not be LAG-ing behind any more

Meghan E. Turnis Department of Immunology; St. Jude Children`s Research Hospital; Memphis, TN USA
,
Alan J. Korman Biologics Discovery California; Bristol-Myers-Squibb; Milpitas, CA USA
,
Charles G. Drake Departments of Oncology; Immunology and Urology; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center; Baltimore, MD USA
&
Dario A.A. Vignali Department of Immunology; St. Jude Children`s Research Hospital; Memphis, TN USACorrespondence[email protected]
Pages 1172-1174 | Received 01 May 2012, Accepted 02 May 2012, Published online: 01 Oct 2012

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Maryann E. Mikucki, Daniel T. Fisher, Amy W. Ku, Michelle M. Appenheimer, Jason B. Muhitch & Sharon S. Evans. (2013) Preconditioning thermal therapy: Flipping the switch on IL-6 for anti-tumour immunity. International Journal of Hyperthermia 29:5, pages 464-473.
Read now

Articles from other publishers (12)

Patricia Ines Back, Kaitlin Rascon, Md Rakibul Islam, Christopher Selby & Ninh M La-Beck. (2023) Targeting immune checkpoint pathways in melanoma: triumphs and challenges. Future Drug Discovery 5:1.
Crossref
Guyu Tang, Jing Liu, Lin Qi & Yuan Li. (2022) The evolving role of checkpoint inhibitors in the treatment of urothelial carcinoma. British Journal of Clinical Pharmacology 89:1, pages 93-113.
Crossref
Leila Jafarzadeh, Elham Masoumi, Keyvan Fallah-Mehrjardi, Hamid Reza Mirzaei & Jamshid Hadjati. (2020) Prolonged Persistence of Chimeric Antigen Receptor (CAR) T Cell in Adoptive Cancer Immunotherapy: Challenges and Ways Forward. Frontiers in Immunology 11.
Crossref
Laura M. McLane, Mohamed S. Abdel-Hakeem & E. John Wherry. (2019) CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer. Annual Review of Immunology 37:1, pages 457-495.
Crossref
Hamid Reza Mirzaei, Hossein Pourghadamyari, Majid Rahmati, Abbas Mohammadi, Javid Sadri Nahand, Abbas Rezaei, Hamed Mirzaei & Jamshid Hadjati. (2018) Gene-knocked out chimeric antigen receptor (CAR) T cells: Tuning up for the next generation cancer immunotherapy. Cancer Letters 423, pages 95-104.
Crossref
Stephen R. Goding, Kyle A. Wilson, Carolyn Rosinsky & Paul Andrew Antony. (2018) PD-L1–Independent Mechanisms Control the Resistance of Melanoma to CD4+ T Cell Adoptive Immunotherapy. The Journal of Immunology 200:9, pages 3304-3311.
Crossref
Zahra Taherian-Esfahani, Atieh Abedin-Do, Elahe Nikpayam, Behnoosh Tasharofi, Akram Ghahghaei Nezamabadi & Soudeh Ghafouri-Fard. (2016) Cancer-Testis Antigens: A Novel Group of Tumor Biomarkers in Ovarian Cancers. Iranian Journal of Cancer Prevention In Press:In Press.
Crossref
Paul D. Rennert. 2016. Novel Immunotherapeutic Approaches to the Treatment of Cancer. Novel Immunotherapeutic Approaches to the Treatment of Cancer 41 58 .
Daniel Sanghoon Shin & Antoni Ribas. (2015) The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?. Current Opinion in Immunology 33, pages 23-35.
Crossref
Stefanie N. Linch, Michael J. McNamara & William L. Redmond. (2015) OX40 Agonists and Combination Immunotherapy: Putting the Pedal to the Metal. Frontiers in Oncology 5.
Crossref
Emese Zsiros, Janos Tanyi, Klara Balint & Lana E. Kandalaft. (2014) Immunotherapy for ovarian cancer. Current Opinion in Oncology 26:5, pages 492-500.
Crossref
Karen S. Sfanos, Heidi A. Hempel & Angelo M. De Marzo. 2014. Inflammation and Cancer. Inflammation and Cancer 153 181 .

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.